Dexfenfluramine increases pulmonary artery smooth muscle intracellular Ca2+, independent of membrane potential

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 277, Issue 3 21-3, 1999, Pages

  Reeve, Helen L ^a,b,e   Archer, Stephen L ^c   Soper, Marjorie ^a   Weir, E Kenneth ^a,d  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF ALBERTA   (Canada)

^e VA MEDICAL CENTER   (United States)

Author keywords

Anorexics; Intracellular calcium; Potassium channels; Sarcoplasmic reticulum

Indexed keywords

AMINOREX; ANOREXIGENIC AGENT; DEXFENFLURAMINE; FENFLURAMINE; POTASSIUM CHANNEL; THAPSIGARGIN;

ANIMAL TISSUE; ARTERY MUSCLE; ARTICLE; CALCIUM CELL LEVEL; CALCIUM TRANSPORT; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; MEMBRANE POTENTIAL; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL; PULMONARY ARTERY; PULMONARY HYPERTENSION; RAT; SARCOPLASMIC RETICULUM;

EID: 0032886632     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.1999.277.3.l662     Document Type: Article

References (18)

1. Abenhaim, L., Y. Moride, F. Brenot, S. Rich, J. Benichou, X. Kurz, T. Higenbottam, C. Oakley, E. Wouters, M. Aubier, G. Simonneau, and B. Bgaud. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. N. Engl. J. Med. 335: 609-616, 1996.
2. Anonymous. Dexfenfluramine. Lancet 337: 1315-1316, 1991.
3. Archer, S. L., K. Djaballah, M. Humbert, E. K. Weir, M. Fartoukh, J. Dall'ava-Santucci, J. C. Mercier, G. Simonneau, and A. Tuan Dinh-Xuan. Nitric oxide deficiency in fenfluramine-and dexfenfluramine-induced pulmonary hypertension. Am. J. Respir. Crit. Care Med. 158: 1061-1067, 1998.
4. 2+ indicators with greatly improved fluorescence properties. J. Biol. Chem. 260: 3440-3450, 1985.
5. 2+ release in hypoxic vasoconstriction of canine pulmonary artery. Br. J. Pharmacol. 122:21-30, 1997.
6. Kaneko, F. T., A. C. Arroliga, R. A. Dweik, S. A. Comhair, D. Laskowski, R. Oppedisano, M. J. Thomassen, and S. C. Erzurum. Biochemical reaction products of nitric oxide as quantitative markers of primary pulmonary hypertension. Am. J. Respir. Crit. Care Med. 158: 917-923, 1998.
7. Loza, J., L. Carpio, G. Lawless, N. Marzec, and R. Dziak. Role of extracellular calcium influx in EGF-induced osteoblastic cell proliferation. Bone 16, Suppl.: 341S-347S, 1995.
8. Loza, J., N. Marzec, S. Simasko, and R. Dziak. Role of epidermal growth factor-induced membrane depolarization and resulting calcium influx in osteoblastic cell proliferation. Cell Calcium 17: 301-306, 1995.
9. + channels in canine pulmonary artery: novel mechanism for hypoxic-induced membrane depolarization. Circ. Res. 77: 131-139, 1995.
10. Pozzan, T., R. Rizzuto, P. Volpe, and J. Meldolesi. Molecular and cellular physiology of intracellular calcium stores. Physiol. Rev. 74: 595-636, 1994.
11. Rae, J., K. Cooper, G. Gates, and M. Watsky. Low access resistance perforated patch recordings using amphotericin B. J. Neurosci. Methods 37: 15-26, 1991.
12. Reeve, H. L., D. P. Nelson, S. L. Archer, and E. K. Weir. Effects of fluoxetine, phentermine, and venlafaxine on pulmonary arterial pressure and electrophysiology. Am. J. Physiol. 276 (Lung Cell. Mol. Physiol. 20): L213-L219, 1999.
13. Rubin, L. J. Primary pulmonary hypertension. N. Engl. J. Med. 336: 111-117, 1997.
14. 2+ATPases. Trends Pharmacol. Sci. 19: 131-135, 1998.
15. Voelkel, N. R., R. M. Tuder, and E. K. Weir. Pathophysiology of primary pulmonary hypertension: from physiology to molecular mechansims. In: Primary Pulmonary Hypertension, edited by L. J. Rubin and S. Rich. New York: Dekker, 1997, vol. 99, p. 83-129. (Lung Biol. Health Dis. Ser.)
16. Weir, E. K., H. L. Reeve, J. M. C. Huang, E. Michelakis, D. P. Nelson, V. Hampl, and S. L. Archer. Anorexic agents aminorex, fenfluramine, and dexfenfluramine inhibit potassium current in rat pulmonary vascular smooth muscle and cause pulmonary vasoconstriction. Circulation 94: 2216-2220, 1996.
17. Yuan, X.-J., R. T. Bright, A. M. Aldinger, and L. J. Rubin. Nitric oxide inhibits serotonin-induced calcium release in pulmonary artery smooth muscle cells. Am. J. Physiol. 272 (Lung Cell. Mol. Physiol. 16): L44-L50, 1997.
18. 2+ entry in vascular smooth muscle cells: nicardipine-sensitive and -insensitive pathways. Am. J. Physiol. 262 (Cell Physiol. 31): C1258-C1265, 1992.